statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	546
SG - Singapore	76
IT - Italia	64
CN - Cina	45
HK - Hong Kong	30
BR - Brasile	27
FI - Finlandia	17
DE - Germania	16
PL - Polonia	12
TR - Turchia	12
FR - Francia	10
GB - Regno Unito	10
ES - Italia	8
RU - Federazione Russa	8
TW - Taiwan	8
AT - Austria	7
KR - Corea	6
CO - Colombia	5
IE - Irlanda	5
NL - Olanda	5
VN - Vietnam	5
YT - Mayotte	5
CI - Costa d'Avorio	4
CZ - Repubblica Ceca	4
EC - Ecuador	4
GP - Guadalupe	4
GR - Grecia	4
JP - Giappone	4
KZ - Kazakistan	4
MU - Mauritius	4
CG - Congo	3
ET - Etiopia	3
HU - Ungheria	3
IR - Iran	3
KG - Kirghizistan	3
MA - Marocco	3
MD - Moldavia	3
ML - Mali	3
MW - Malawi	3
NA - Namibia	3
NZ - Nuova Zelanda	3
PE - Perù	3
PY - Paraguay	3
RO - Romania	3
SE - Svezia	3
SN - Senegal	3
UA - Ucraina	3
UY - Uruguay	3
UZ - Uzbekistan	3
AR - Argentina	2
BF - Burkina Faso	2
BJ - Benin	2
BW - Botswana	2
CA - Canada	2
CD - Congo	2
CL - Cile	2
DJ - Gibuti	2
EE - Estonia	2
EG - Egitto	2
GF - Guiana Francese	2
IL - Israele	2
JM - Giamaica	2
MG - Madagascar	2
MK - Macedonia	2
MX - Messico	2
NI - Nicaragua	2
NO - Norvegia	2
PT - Portogallo	2
SA - Arabia Saudita	2
TH - Thailandia	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
UG - Uganda	2
YE - Yemen	2
AD - Andorra	1
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AO - Angola	1
AU - Australia	1
AZ - Azerbaigian	1
BD - Bangladesh	1
BE - Belgio	1
BG - Bulgaria	1
BO - Bolivia	1
BY - Bielorussia	1
BZ - Belize	1
CH - Svizzera	1
CR - Costa Rica	1
CU - Cuba	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
GA - Gabon	1
GE - Georgia	1
GN - Guinea	1
HT - Haiti	1
ID - Indonesia	1
JO - Giordania	1
KH - Cambogia	1
KY - Cayman, isole	1
Totale	1.092

Nome	#
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells.	207
DOPAL-induced impairment of aSynuclein and cellular proteostasis as molecular mechanism to enhance neuronal vulnerability in Parkinson's disease.	131
Impaired dopamine metabolism in Parkinson's disease pathogenesis	123
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance	118
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease	99
Photoresponsive Prion-Mimic Foldamer to Induce Controlled Protein Aggregation	91
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease	87
Metformin repurposing for parkinson disease therapy: Opportunities and challenges	83
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype	77
Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis	62
Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for “Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo”	61
Totale	1.139

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	66	0	0	0	11	2	0	0	24	6	16	3	4
2021/2022	122	11	6	5	8	3	7	2	22	14	13	3	28
2022/2023	162	24	23	9	25	13	22	3	13	25	2	2	1
2023/2024	82	4	12	5	12	2	3	7	7	4	3	12	11
2024/2025	315	8	6	16	12	44	15	32	31	28	11	43	69
2025/2026	297	79	68	145	5	0	0	0	0	0	0	0	0
Totale													1.139